NCT05672095 2025-05-23Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian CancerCity of Hope Medical CenterPhase 1/2 Withdrawn
NCT05126342 2025-04-06Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPiAGO Research GmbHPhase 2 Withdrawn